Current therapeutic landscape and resistance mechanisms to larotrectinib.

Xie, Weiji; Xu, Jiaqian; Lu, Suying; Zhang, Yizhuo

Xie, Weiji; Xu, Jiaqian; Lu, Suying; Zhang, Yizhuo.

Afiliação

Xie W; Department of Pediatric Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.
Xu J; Department of Pediatric Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.
Lu S; Department of Pediatric Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.
Zhang Y; Department of Pediatric Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.

Cancer Biol Med ; 20(12)2024 02 05.

Article em En | MEDLINE | ID: mdl-38318928

Assuntos

Neoplasias; Humanos; Neoplasias/tratamento farmacológico; Pirazóis/farmacologia; Pirazóis/uso terapêutico; Pirimidinas/farmacologia; Pirimidinas/uso terapêutico

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Limite: Humans Idioma: En Revista: Cancer Biol Med Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China País de publicação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google